Novolog 100 unit/ML flexpen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1U84
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,844
Award facts
- Contract value 100% obligated
- $11,843.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $11,843.89 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract was competitively awarded without a set-aside designation and is scheduled for completion by January 14, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work from its corporate office location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 31, 2031, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The NovoLog insulin product delivery supports the federal government's commitment to providing essential diabetes management medications to military treatment facilities, veterans' healthcare programs, and other government medical institutions. As a critical pharmaceutical vendor in the DLA supply chain, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill federal procurement requirements for specialized medications across multiple therapeutic domains, including diabetes care products that are integral to military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1U84?
SPE2DR26F1U84 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1U84 worth?
The government has obligated $11,844 on SPE2DR26F1U84.
Is contract SPE2DR26F1U84 an order under another contract?
Yes. SPE2DR26F1U84 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U84 competed?
The extent of competition for SPE2DR26F1U84 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award